Webinars & Events

Knome Closes $13 Million Financing Round

CAMBRIDGE, MA – January 10, 2014 – Knome, Inc. announced that it has successfully closed a $13 Million financing round led by current investors. The funds will be used to promote growth and expansion of its genomic services and software systems businesses.

Since 2007, Knome, based in Cambridge, Massachusetts, has been a pioneer in the fast growing business of interpretation of next generation sequencing (NGS) genomic data. The company has used its bioinformatics expertise and proprietary technology platform across more than 130 projects for biopharmaceutical companies and academic institutions.

Knome is now developing its technology into products that support clinical laboratory operations. As previously announced, Knome offers a fully integrated system for the management and interpretation of human genome sequence data. The system is the combination of analytical and workflow software, knoSOFT, and a powerful grid computing platform, the knoSYS™100. The first systems were delivered to NGS clinical labs in 2013. “We see a great need for our products in commercial and academic clinical labs adopting NGS technology in their move into precision medicine,” said Knome CEO Wolfgang Daum. “The knoSYS provides a secure, fast computing environment behind the customer’s firewall, while knoSOFT encapsulates the lab’s expertise and access to the public and institutional knowledge needed to provide the timely, reproducible, high quality services their customers require.”

For more information visit www.knome.com, or contact Jorge Conde, [email protected], 617-715-1000 x2001.

About Knome

Knome Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome’s big data technologies are helping to pave the healthcare industry’s transition to molecular-based, precision medicine. www.knome.com.

###

Follow Us On

 Events

Knome Hosts Charity Gala for Children’s Hospital Boston

On Friday, May 11, the Knome team hosted a black tie charity gala benefiting Children’s Hospital Boston. Hundreds of attendees gathered in the beautiful atrium right outside our offices here at the Davenport building in Cambridge. We were honored to have Dr. George...

Webinar: Sequence Once. Query Often.

Genomic medicine through the in silico lens of leading molecular and translational laboratoriesPresenter: Ben Salisbury, PhD, SVP of Clinical Products at KnomeDate: December 11, 2014Abstract “Sequence today for questions of today and questions of tomorrow.” In a Knome...

Webinar: The Business of Genomic Testing

Presenter: James M. Crawford, MD, PhD, Executive Director and Senior Vice President, Laboratory Services at North Shore-LIJ Health System and Professor and Chair, Department of Pathology and Laboratory Medicine at Hofstra North Shore-LIJ School of Medicine...